Mahmoud Malas,MD,MHS (@malas_mahmoud) 's Twitter Profile
Mahmoud Malas,MD,MHS

@malas_mahmoud

Professor In Residence Chief Vascular and Endovascular Surgery @UCSDMedSchool, Vice Chair of Surgery for Clinical Research @UCSDsurgery

ID: 872833949546012672

calendar_today08-06-2017 15:13:24

923 Tweet

2,2K Followers

361 Following

Mahmoud Malas,MD,MHS (@malas_mahmoud) 's Twitter Profile Photo

Great discussion American Surgical of our PSM analysis of TCAR vs. CEA three-years outcomes showing no difference in stroke rate and slight decrease in three-years survival in Sx patients. TCAR patients are older with significantly higher baseline morbidities

Great discussion <a href="/AmerSurg/">American Surgical</a>  of our PSM analysis of TCAR vs. CEA three-years outcomes showing no difference in stroke rate and slight decrease in three-years survival in Sx patients. TCAR patients are older with significantly higher baseline morbidities
Mahmoud Malas,MD,MHS (@malas_mahmoud) 's Twitter Profile Photo

Great SoCal Vascular & Kaiser Endovasc meetings excellent talks Dr Veith frank arko Shipra Arya MD strong presentations by all institutions, very proud of UCSD vascular team Nadin Elsayed Daniel Willie-Permor congrats Dr. Patel on best presentation award Andrew Barleben president elect

Great <a href="/VascularSocal/">SoCal Vascular</a> &amp; Kaiser Endovasc meetings excellent talks Dr Veith <a href="/farkomd/">frank arko</a> <a href="/ShipraAryaMD/">Shipra Arya MD</a> strong presentations by all institutions, very proud of UCSD vascular team <a href="/NadinElsayed1/">Nadin Elsayed</a> <a href="/DrWilliePermor/">Daniel Willie-Permor</a> congrats Dr. Patel on best presentation award <a href="/AndrewBarleben/">Andrew Barleben</a> president elect
Vascular SVS (@vascularsvs) 's Twitter Profile Photo

Don't forget to register and attend Wednesday's webinar to introduce the candidates for the upcoming SVS Election. This is an opportunity for you to ask questions and get to know who you will be voting for once the polls open. Learn more and register now: vascular.org/vascular-speci…

Don't forget to register and attend Wednesday's webinar to introduce the candidates for the upcoming SVS Election. This is an opportunity for you to ask questions and get to know who you will be voting for once the polls open. Learn more and register now: vascular.org/vascular-speci…
Vascular SVS (@vascularsvs) 's Twitter Profile Photo

#VAM23 will be packed with educational content presented by experts in the field. Check out this video from the “How I do it” session to get a sneak peek of what you can expect at this year’s meeting. Experience the full session at VAM23; register now: vascular.org/vam-2023/progr…

JVS-Cases Innovations and Techniques (@jvascsurgcit) 's Twitter Profile Photo

Q4: With evolving BMT, will asymptomatic revascularization become obsolete? How do we optimize training of comprehensive carotid management while maintaining appropriateness of care? #jvscitXchat Steven Maximus KatDiLosaMD @rmotagsanahalli Caitlin Hicks MD, MS Mahmoud Malas,MD,MHS

Mahmoud Malas,MD,MHS (@malas_mahmoud) 's Twitter Profile Photo

Super proud of Dr. Elsie Ross Elsie Ross Associate Professor of Vascular Surgery In-Residence UC San Diego Surgery for securing funding of her R-01 using #Al for early Detection of Peripheral Artery Disease (AID-PAD)

Super proud of Dr. Elsie Ross <a href="/tyingwithpolish/">Elsie Ross</a> Associate
Professor of Vascular Surgery In-Residence <a href="/UCSDsurgery/">UC San Diego Surgery</a> for securing funding of her R-01 using #Al for early
Detection of Peripheral Artery
Disease (AID-PAD)
Christopher A. Longhurst, MD (@calonghurst) 's Twitter Profile Photo

Proud to be part of the new Center for Healthcare Cybersecurity UC San Diego Health Sciences! Thank you Drs. Tully and Dameff for your leadership in this important space 🖥️ 🏥

Mahmoud Malas,MD,MHS (@malas_mahmoud) 's Twitter Profile Photo

Superb presentation Nishi Vootukuru Vascular SVS #VAM24 significant number of bedridden/wheelchair asymptomatic patients undergoing CEA with 2.6folds increase 30day death risk compared to ambulatory patients. These patients are better off with BMT UC San Diego Surgery

Superb presentation <a href="/Nishi_Vootukuru/">Nishi Vootukuru</a>  <a href="/VascularSVS/">Vascular SVS</a> #VAM24 significant number of bedridden/wheelchair asymptomatic patients undergoing CEA with 2.6folds increase 30day death risk compared to ambulatory patients.  These patients are better off with BMT <a href="/UCSDsurgery/">UC San Diego Surgery</a>
Ted Gifford (@tedgiffordmd) 's Twitter Profile Photo

Kicking off day 2 of #VAM24 Kate McGinigle, MD MPH shares stratified analysis in BEST-CLI Trial. Females had lower MALE with any open conduit SSGSV + alternative conduits compared to endo, and lower rates of major amputation compared to males.

Kicking off day 2 of #VAM24 <a href="/KateMcGinigleMD/">Kate McGinigle, MD MPH</a> shares stratified analysis in <a href="/BEST_CLI/">BEST-CLI Trial</a>. Females had lower MALE with any open conduit SSGSV + alternative conduits compared to endo, and lower rates of major amputation compared to males.
Mahmoud Malas,MD,MHS (@malas_mahmoud) 's Twitter Profile Photo

Very comprehensive presidential address Joseph L. Mills MD emphasizing numerous remarkable achievements by Vascular SVS #VAM24 proud to be a vascular surgeon and a member of our society

Very comprehensive presidential address <a href="/jmills1955/">Joseph L. Mills MD</a> emphasizing numerous remarkable achievements by <a href="/VascularSVS/">Vascular SVS</a>  #VAM24 proud to be a vascular surgeon and a member of our society
Mahmoud Malas,MD,MHS (@malas_mahmoud) 's Twitter Profile Photo

Excited to announce our vascular faculty recruitment UC San Diego Surgery Humbled by our team’s accomplishments: matured 0/5 residency, >10,000 accredited vasc lab studies/yr, AAHC accredited OBL, CLEVER with 40 pubs/yr, IDE, and home of vascular RO1! apol-recruit.ucsd.edu/JPF04073